DTIM
AZN icon

Danda Trouve Investment Management’s AstraZeneca AZN Stock Holding History

Danda Trouve Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13
Closed -$1K – 139
2020
Q2 		$1K Buy
+13
New +$1.34K ﹤0.01% 137

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Danda Trouve Investment Management's AZN Position: Q3 2020 in Review

Danda Trouve Investment Management sold out of AstraZeneca (AZN) in Q3 2020, closing a stake of 13 shares — an estimated $1K sold.

Danda Trouve Investment Management first reported a position in AZN in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • Danda Trouve Investment Management reported no remaining AstraZeneca position as of Q3 2020 after selling out during the quarter.
  • Danda Trouve Investment Management sold 13 AstraZeneca shares in Q3 2020, an estimated $1K.
  • Danda Trouve Investment Management first reported a position in AstraZeneca in Q2 2020 and held it in 1 quarter.
  • Danda Trouve Investment Management's AstraZeneca position peaked at $1K in Q2 2020.
  • 723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on Danda Trouve Investment Management's 13F filing for Q3 2020, filed 28 Oct 2020.